5q- Syndrome

Search Trials
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
Status:
Active, not recruiting
Last Changed:
Dec 5, 2018
First Changed:
Mar 5, 2009
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
fludarabine phosphatemelphalantotal-body irradiationallogeneic hematopoietic stem cell transplantationanti-thymocyte globulin
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Status:
Recruiting
Last Changed:
Dec 24, 2018
First Changed:
Jun 29, 2011
Disease(s):
Adult Acute Lymphoblastic Leukemia in Remission
Intervention(s):
FludarabineBusulfanTotal Body Irradiation (TBI)Donor Lymphocyte Infusion (DLI)Cyclophosphamide (CY)TacrolimusMycophenolate mofetilAllogeneic hematopoietic stem cell transplantationPeripheral blood stem cell transplantation (PBSCT)
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
Status:
Active, not recruiting
Last Changed:
Dec 7, 2018
First Changed:
Jan 27, 2003
Disease(s):
Acute Myeloid Leukemia/Transient Myeloproliferative Disorder
Intervention(s):
fludarabine phosphatetotal-body irradiationperipheral blood stem cell transplantationallogeneic hematopoietic stem cell transplantationcyclosporinemycophenolate mofetillaboratory biomarker analysis
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
Status:
Active, not recruiting
Last Changed:
Jan 14, 2019
First Changed:
Aug 5, 2004
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
fludarabine phosphatetotal-body irradiationmycophenolate mofetiltacrolimusperipheral blood stem cell transplantationnonmyeloablative allogeneic hematopoietic stem cell transplantationlaboratory biomarker analysis
Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
Status:
Completed
Last Changed:
Apr 2, 2014
First Changed:
Nov 3, 2010
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
paliferminflow cytometrylaboratory biomarker analysispharmacological study

Connect. Empower. Inspire.